ArticleTherapeutics and clinical risk management2014
Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage.
Habip Gedik et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it